Abstract:Portopulmonary hypertension (POPH) is a form of pulmonary arterial hypertension (PAH) in the setting of portal hypertension, and is associated with a poor prognosis [1]. The underling etiological cause of POPH is poorly understood [1]. Previously we have reported T cell-mediated immune deficiency or compromise in patients with chronic thromboembolic pulmonary hypertension (CTEPH), idiopathic pulmonary hypertension (IPH), and acute pulmonary embolism (APE) [2, 3]. Here we report natural killer cell-mediated immune deficiency or compromise in patients with POPH. Nine patients (4 male, 5 female) diagnosed with POPH in Shanghai Tongji Hospital from year 2010 to 2011 were recruited in the present study, with a mean age of 65 ±19 years (30–82 years). The diagnosis of POPH is based on the hemodynamic criteria including portal hypertension and/or liver disease (clinical diagnosis) [4], pulmonary artery systolic pressure > 40 mm Hg at rest, pulmonary vascular resistance > 240 dynes × s × cm−5, and pulmonary artery occlusion pressure 12 [1]. We firstly detected the cluster of differentiation (CD) on the T cell surface. To our surprise, unlike the changes we previously reported in CTEPH, IPH, or APE, only slight changes of CD3+, CD4+ or CD8+ T cells were observed in POPH patients (Table I and Figures 1A–C). Interestingly, the number of CD16+CD56, which reflects the function of natural killer cell, was decreased in five patients with POPH (55.6%) (Table I and Figure 1D) [5]. Figure 1 Changes of T and NK cells of the patients enrolled in this study Table I The etiology, Child-Pugh Class, pulmonary artery systolic pressure, and the clusters of differentiation on T and NK cells of the patients enrolled in this study T cell-mediated immune deficiency or compromise has been reported in patients with CTEPH, IPH, and APE [2, 3]. In the present study, we failed to detect obvious cell-mediated immune changes. Natural killer cells, accounting for 15% of peripheral blood lymphocytes, are well-known unique effectors of the innate immune system as they can recognize stressed cells in the absence of antibodies and MHC [3]. As the role of natural killer cells is analogous to that of cytotoxic T cells [5], we detected their surface markers CD16 (FcγRIII) and CD56 in POPH patients and identified a natural killer cell-mediated immune deficiency or compromise in patients with POPH. Immune deficiency or compromise of natural killer cells is usually caused by virus infection, cancer, or immunosuppressive drugs [5]. In this study, malignant tumors or use of immunosuppressive drugs were excluded in these 9 patients; therefore the immune deficiency or compromise of natural killer cells is most likely due to virus infection. Our study indicated that the virus-killing function of natural killer cells is compromised in patients with POPH. The POPH might be a disease of acquired natural killer cell-mediated immune deficiency, and virus infection may be an important etiological factor of POPH. We also speculate that the pathogenic virus infection in POPH patients may be different from those in CTEPH, IPH, and APE.

Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension.

Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency

Natural Killer Cell-Mediated Immune Deficiency or Compromise in Patients with Portopulmonary Hypertension

Compromised Natural Killer Cells in Pulmonary Embolism.

Transcriptome analyses reveal common immune system dysregulation in PAH patients and Kcnk3‐deficient rats

Abstract 9814: Nf-?B Inhibition Prevents Vascular Obliteration and Improves Immune Regulation in Severe Pulmonary Arterial Hypertension

A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension

Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension

KLF6 in Pulmonary Hypertension: The Dual Role of Friend and Foe

Endogenous Retroviral Elements Generate Pathologic Neutrophils and Elastase Rich Exosomes in Pulmonary Arterial Hypertension

Lung Natural Killer Cells Play A Major Counter-Regulatory Role In Pulmonary Vascular Hyperpermeability After Myocardial Infarction

Lymphocyte Involvement in the Pathology of Pulmonary Arterial Hypertension

Hypoxia profoundly alters Natural Killer cell phenotype and function: implications for immunotherapy within the solid tumor microenvironment

Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension

Natural Killer Cells as a Further Insight into the Course of Chronic Obstructive Pulmonary Disease

Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension

IL-6/gp130 signaling in CD4+ T cells drives the pathogenesis of pulmonary hypertension

PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension

Abstract 4137845: A Single-Cell Lung Atlas of Human Pulmonary Arterial Hypertension

Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α